Literature DB >> 35487602

Hyponatremia in Cirrhosis.

Helbert Rondon-Berrios1, Juan Carlos Q Velez2.   

Abstract

Hyponatremia is the most common electrolyte disorder encountered in clinical practice, and it is a common complication of cirrhosis reflecting an increase in nonosmotic secretion of arginine vasopressin as a result of of the circulatory dysfunction that is characteristic of advanced liver disease. Hyponatremia in cirrhosis has been associated with poor clinical outcomes including increased risk of morbidity and mortality, poor quality of life, and heightened health care utilization. Despite this, the treatment of hyponatremia in cirrhosis remains challenging as conventional therapies such as fluid restriction are frequently ineffective. In this review, we discuss the epidemiology, clinical outcomes, pathogenesis, etiology, evaluation, and management of hyponatremia in cirrhosis.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albumin; Arginine vasopressin; Ascites; Central pontine myelinolysis; Cirrhosis; Hyponatremia; Liver transplantation; Osmotic demyelination syndrome

Mesh:

Year:  2022        PMID: 35487602      PMCID: PMC9060324          DOI: 10.1016/j.cld.2022.01.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.265


  78 in total

1.  Total exchangeable sodium, total exchangeable potassium, and total body water in edematous patients with cirrhosis of the liver and congestive heart failure.

Authors:  L W BIRKENFELD; J LEIBMAN; M P O'MEARA; I S EDELMAN
Journal:  J Clin Invest       Date:  1958-05       Impact factor: 14.808

2.  Relative adrenal insufficiency in cirrhotic patients with ascites (hepatoadrenal syndrome).

Authors:  Rajiv Ranjan Singh; Rama Walia; Naresh Sachdeva; Ashish Bhalla; Akash Singh; Virendra Singh
Journal:  Dig Liver Dis       Date:  2018-05-23       Impact factor: 4.088

Review 3.  Hyponatremia in cirrhosis: from pathogenesis to treatment.

Authors:  P Ginés; T Berl; M Bernardi; D G Bichet; G Hamon; W Jiménez; J F Liard; P Y Martin; R W Schrier
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

4.  Risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a single-center study.

Authors:  Chiara Crivellin; Annachiara Cagnin; Renzo Manara; Patrizia Boccagni; Umberto Cillo; Paolo Feltracco; Stefania Barbieri; Alberto Ferrarese; Giacomo Germani; Francesco Paolo Russo; Patrizia Burra; Marco Senzolo
Journal:  Transplantation       Date:  2015-06       Impact factor: 4.939

5.  Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.

Authors:  Florence Wong; S Chris Pappas; Michael P Curry; K Rajender Reddy; Raymond A Rubin; Michael K Porayko; Stevan A Gonzalez; Khalid Mumtaz; Nicholas Lim; Douglas A Simonetto; Pratima Sharma; Arun J Sanyal; Marlyn J Mayo; R Todd Frederick; Shannon Escalante; Khurram Jamil
Journal:  N Engl J Med       Date:  2021-03-04       Impact factor: 91.245

Review 6.  Hyponatremia in Cirrhosis: Implications for Liver Transplantation.

Authors:  Michael Leise; Andrés Cárdenas
Journal:  Liver Transpl       Date:  2018-11       Impact factor: 5.799

7.  Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.

Authors:  Robert W Schrier; Peter Gross; Mihai Gheorghiade; Tomas Berl; Joseph G Verbalis; Frank S Czerwiec; Cesare Orlandi
Journal:  N Engl J Med       Date:  2006-11-14       Impact factor: 91.245

8.  The new liver allocation system: moving toward evidence-based transplantation policy.

Authors:  Richard B Freeman; Russell H Wiesner; Ann Harper; Sue V McDiarmid; Jack Lake; Erick Edwards; Robert Merion; Robert Wolfe; Jeremiah Turcotte; Lewis Teperman
Journal:  Liver Transpl       Date:  2002-09       Impact factor: 5.799

9.  Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy.

Authors:  D Häussinger; J Laubenberger; S vom Dahl; T Ernst; S Bayer; M Langer; W Gerok; J Hennig
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

Review 10.  Well tolerated spironolactone-related hyponatremia.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-04       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.